On Thursday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: Peabody Energy Corp. (NYSE:BTU), Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), Midway Gold Corp. (NYSEMKT:MDW), Exact Sciences Corporation (NASDAQ:EXAS)
Peabody Energy Corp. (NYSE:BTU), with shares declined -11.81%, closed at $5.60.
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), with shares dropped -9.21%, settled at $23.95.
Midway Gold Corp. (NYSEMKT:MDW), with shares dipped -8.75%, and closed at $0.315, hitting new 52-week low of $0.31.
Exact Sciences Corporation (NASDAQ:EXAS), plummeted -7.50%, and closed at $21.33.
Latest NEWS regarding these Stocks are depicted underneath:
Peabody Energy Corp. (NYSE:BTU)
Formerly on March 16, Peabody Energy Corp. (BTU), declared that it successfully accomplished its formerly declared offering of $1.0 billion aggregate principal amount of 10% senior secured second lien notes due 2022. Peabody will use the net proceeds from the sale of the notes to fund the formerly declared tender offer to purchase for cash any and all of the $650 million aggregate principal amount outstanding of its 7 3/8% Senior Notes due 2016, to fund the redemption of all 2016 notes that are not tendered in the tender offer and for general corporate purposes, which may comprise the payment of its federal coal lease expenditures.
The notes are secured by a second-priority lien on all of the assets that secure the corporation’s and the guarantors’ obligations under the corporation’s senior secured credit facility, subject to permitted liens and other limitations.
Peabody Energy Corporation engages in the mining of coal. The corporation operates through Western U.S. Mining, Midwestern U.S. Mining, Australian Mining, Trading and Brokerage, and Corporate and Other segments. It is involved in mining and sale of thermal coal to electric utilities and metallurgical coal for industrial customers.
Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT)
Sagent Pharmaceuticals, Inc. (SGNT), declared that Jeffrey Yordon, Chairman and Chief Executive Officer, has informed the Board of his decision to retire from the Corporation. He will remain a member of the Board. Frank Kung, Ph.D., a well-regarded industry executive and a member of Sagent’s Board since 2006, has been named Chairman. The Board will right away start the search for a new CEO. In the interim, the Board has formed an Executive Administration Committee to lead the Corporation.
Sagent also declared that James Hussey, who served as the Corporation’s President, has decided to leave the Corporation.
Sagent Pharmaceuticals, Inc., a specialty pharmaceutical corporation, develops, sources, manufactures, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in North America.
Midway Gold Corp. (NYSEMKT:MDW)
Formerly on March 16, Midway Gold Corp. (MDW), declared financial results for the period ended December 31, 2014. These results were filed recently with the United States Securities and Exchange Commission in the Corporation’s annual report on Form 10-K and with the relevant securities regulators in Canada.
Recent Developments:
Pan Project:
- Mining at Pan reached steady state of 55k tons/day in January 2015.
- Cyanide was introduced to the irrigation system March 6, 2015. Breakthrough was realized March 7.
- Most of the ADR (Adsorption-Desorption-Recovery) plant has been commissioned counting the Carbon-in-Columns circuit.
- Commissioning of the refinery has commenced.
- Drilling and development of a replacement water well is complete.
- Installation of assay laboratory began March 11 and is predictable to be complete mid-April.
- Midway anticipates first gold production from the Pan Mine on March 30, 2015.
- Midway anticipates noteworthy production in April and May as more than 3 million tons have already been loaded onto the leach pad since mining commenced in September 2014 and more than 2 million tons went under leach when cyanide was introduced.
Gold Rock Project:
Draft Environmental Influence Statement was published February 13, 2015. The federal permitting process is predictable to conclude by the end of 2015.
Spring Valley Project:
Barrick Gold published an initial resource for the Spring Valley project, and anticipates to complete pre-feasibility in late 2015.
Midway Gold Corp. engages in the attainment, exploration, and development of gold and silver mineral properties in North America. The corporation holds interest in the Pan and Gold Rock Projects located along the prolific Battle Mountain/Eureka gold trend; the Spring Valley property, which is located in the Spring Valley Mining District, Pershing County, Nevada.
Exact Sciences Corporation (NASDAQ:EXAS)
Formerly on March 11, Exact Sciences Corporation (EXAS), declared Wheaton Franciscan Healthcare is the first healthcare system in Milwaukee to offer Cologuard®, the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer. Cologuard makes it easy for average risk patients 50 years and older to get screened at their convenience and in the privacy and comfort of their own home without having to worry about taking time off work to prepare for an invasive procedure.
Cologuard analyzes a person’s stool to detect both altered DNA and blood known to be associated with colorectal cancer or pre-cancer. Cologuard is accessible by prescription only for people age 50 and over at average risk for colon cancer (no preceding history with polyps or cancer, and no family history with colon cancer.)
Colorectal cancer is the second-leading cancer-related cause of death in the United States. It is often considered a highly preventable cancer, yet is the least prevented cancer due to the lack of patient compliance with current screening options. Most colorectal cancers develop slowly over several years. Before cancer develops, a polyp—a non-cancerous growth—usually appears on the inner lining of the colon or rectum. Identifying and removing these polyps, through routine screenings, can effectively prevent colorectal cancer. For those whose cancer is detected at an early stage, the five-year survival rate can be greater than 90 percent, making routine screening critical. Unfortunately, 23 million Americans aged 50 and over do not get screened as recommended.
Exact Sciences Corporation, a molecular diagnostics corporation, focuses on developing non-invasive colorectal cancer screening products. The corporation develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
